| Distress | Uncertainty | Total | |||
---|---|---|---|---|---|---|
Mean (SD) | p-value | Mean (SD) | p-value | Mean (SD) | p-value | |
Partnered | Â | 0.84 | Â | 0.24 | Â | 0.37 |
 Yes | 6.0 (6.8) |  | 12.0 (9.6) |  | 25.0 (16.3) |  |
 No | 5.6 (6.4) |  | 14.8 (7.9) |  | 28.7 (15.8) |  |
Children | Â | 0.10 | Â | 0.006 | Â | 0.02 |
 Yes | 7.4 (7.2) |  | 16.2 (8.6) |  | 31.4 (16.3) |  |
 No | 4.5 (6.1) |  | 10.1 (8.5) |  | 21.9 (15.0) |  |
Post-secondary education | Â | 0.17 | Â | 0.80 | Â | 0.64 |
 Yes | 6.2 (7.0) |  | 13.0 (9.1) |  | 26.9 (16.6) |  |
 No | 3.8 (4.3) |  | 13.8 (8.7) |  | 24.3 (13.7) |  |
Household income | Â | 0.40 | Â | 0.09 | Â | 0.29 |
 <  75, 000 CAD | 7.9 (7.5) |  | 17.0 (10.0) |  | 32.4 (18.0) |  |
 ≥ 75, 000 CAD | 6.0 (6.5) |  | 11.9 (8.6) |  | 26.6 (16.5) |  |
Race/Ethnicity | Â | 0.75 | Â | 0.37 | Â | 0.70 |
 White | 6.1 (7.0) |  | 12.5 (8.3) |  | 26.1 (16.0) |  |
 Other | 5.4 (6.1) |  | 14.9 (10.2) |  | 27.9 (15.1) |  |
Cancer stage | Â | 0.89 | Â | 0.73 | Â | 0.71 |
 I/II | 6.8 (7.3) |  | 14.3 (8.3) |  | 28.8 (15.3) |  |
 III/IV | 5.9 (6.8) |  | 13.1 (9.2) |  | 26.6 (16.6) |  |
Tumour results | Â | 0.23 | Â | 0.16 | Â | 0.10 |
 Positive | 7.7 (7.7) |  | 15.6 (9.1) |  | 31.9 (17.4) |  |
 Negative | 5.3 (6.3) |  | 12.2 (8.9) |  | 24.6 (15.4) |  |
Primary treatment | Â | 0.002 | Â | 0.009 | Â | 0.02 |
 Neoadjuvant chemotherapy | 3.0 (4.8) |  | 9.6 (7.5) |  | 21.1 (12.8) |  |
 Surgery | 7.9 (7.2) |  | 15.6 (9.2) |  | 30.4 (17.4) |  |
Personal history breast cancer | Â | 0.004 | Â | 0.63 | Â | 0.35 |
 Yes | 2.0 (2.0) |  | 11.3 (8.1) |  | 20.3 (9.8) |  |
 No | 6.4 (6.9) |  | 13.5 (9.1) |  | 27.5 (16.7) |  |
Family history breast/ovarian cancer | Â | 0.13 | Â | 0.46 | Â | 0.17 |
 Yes | 7.4 (7.5) |  | 14.2 (9.4) |  | 29.9 (17.9) |  |
 No | 4.8 (5.9) |  | 12.5 (8.7) |  | 24.2 (14.4) |  |
Previous genetic testing in family | Â | 0.77 | Â | 0.91 | Â | 0.81 |
 Yes | 6.7 (7.3) |  | 13.7 (9.5) |  | 28.3 (17.7) |  |
 No | 6.0 (6.8) |  | 13.4 (9.0) |  | 27.0 (16.1) |  |
Genetic counselling prior to survey | Â | 0.45 | Â | 0.56 | Â | 0.21 |
 Yes | 5.3 (6.9) |  | 12.5 (9.2) |  | 24.0 (15.6) |  |
 No | 6.6 (6.7) |  | 13.9 (8.9) |  | 29.2 (16.7) |  |